000			01967 a2200505 4500
005			20250517225441.0
264		0	_c20190909
008			201909s 0 0 eng d
022			_a1815-7920
024	7		_a10.5588/ijtld.17.0515 _2doi
040			_aNLM _beng _cNLM
100	1		_aRajoli, R K R
245	0	0	_aModelling the long-acting administration of anti-tuberculosis agents using PBPK: a proof of concept study. _h[electronic resource]
260			_bThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _c08 2018
300			_a937-944 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAntitubercular Agents _xadministration & dosage
650	0	4	_aDiarylquinolines _xadministration & dosage
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Liberation
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInjections, Intramuscular
650	0	4	_aIsoniazid _xadministration & dosage
650	0	4	_aLatent Tuberculosis _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNitroimidazoles _xadministration & dosage
650	0	4	_aOxazoles _xadministration & dosage
650	0	4	_aProof of Concept Study
650	0	4	_aRifampin _xadministration & dosage
650	0	4	_aTreatment Outcome
650	0	4	_aYoung Adult
700	1		_aPodany, A T
700	1		_aMoss, D M
700	1		_aSwindells, S
700	1		_aFlexner, C
700	1		_aOwen, A
700	1		_aSiccardi, M
773	0		_tThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _gvol. 22 _gno. 8 _gp. 937-944
856	4	0	_uhttps://doi.org/10.5588/ijtld.17.0515 _zAvailable from publisher's website
999			_c28617344 _d28617344